课题基金 / 基金详情

Experimental chemotherapy of anti-human melanoma antibody conjugated antitumor agent.

Experimental chemotherapy of anti-human melanoma antibody conjugated antitumor agent.
抗人黑色素瘤抗体缀合抗肿瘤剂的实验化疗。
批准号:
04454498
负责人:
INUI Madoka
金额:
$4.35万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

INUI Madoka的其他基金

相似基金

相关文献

中文摘要
翻译
将纯化的抗人牙周黑色素瘤细胞株(HMG)的单抗(IA6-C2)及其Fab‘组分偶联到顺铂(CDDP)脂质体上。研究了脂质体(Lip-CDDP、抗-Lip-CDDP、Fab‘-Lip-CDDP)对HMG细胞的杀伤作用。用蛋白A琼脂糖亲和层析法纯化了单抗,并对其进行了药代动力学研究。用N-hydroxysuccinimidyl-3-(pridylditio)-propionate将单抗与脂质体偶联,用羟基自由基将单抗与脂质体偶联。以磷脂酰胆碱、胆固醇和3-(2-吡啶二硫)丙酰二棕榈酰磷脂酰乙醇胺(摩尔比,26/10/0.4)混合制成脂质体。用原子吸收光谱仪测定铂浓度时,CDDP的包封率为3%。在37゚C培养液(RPMI1640含20%胎牛血清)和4゚C PBS培养液中检测Lip-CDDP的释放量。在PBS中24 h和48 h的释放率分别为56%和72%,在PBS中24 h和48 h的释放率分别为12%和14%。Lip-CDDP在4゚C PBS中稳定48 h。单抗-Lip-CDDP体外抗HMG细胞活性为Lip-CDDP的2.1倍和CDDP的20倍。裸鼠体内铂浓度在裸鼠体内分别为Lip-CDDP和Lip-CDDP的1.4倍和2倍,肾组织中则分别为Lip-CDDP和CDDP的0.7倍和0.5倍。
英文摘要
A purified monoclonal antibody (IA6-C2) to a human melanoma cell line from gingiva (HMG) and its Fab' fraction were coupled on Cisplatinum (CDDP) entrapped liposome. The effect of liposomes (Lip-CDDP, Ab-Lip-CDDP, Fab'-Lip-CDDP) against HMG cell was investigated. The Pharmocokinetics of these liposomes in HMG tumor xenografted nude mice were also examined.A MoAb was purified with protein A agarose affinity chromatography. N-hydroxysuccinimidyl-3-(pridylditio)-propionate (SPDP) was used for conjugation of MoAb to the liposome, and SH radical of MoAb was used for conjugation of Fab' to the liposome. The liposome was produced, mixing of phosphatidylcholine, cholesterol and 3-(2-pyridyldithio) propionyldipalmitoyl-phosphatidylethanolamine (molar ratio, 26/10/0.4). The encapsulated ratio of CDDP was 3% when platinum concentration was measured with atomic absorption spectrophotometer. The releasing CDDP from Lip-CDDP was tested in 37゚C culture medium (RPMI 1640 contained 20% FBS) and in 4゚C PBS for stability. The releasing ratio was 56% after 24 hrs and 72% after 48 hrs in culture medium, and 12% after 24 hrs and 14% after 48 hrs in PBS.The Lip-CDDP showed to stabilize in 4゚C PBS for 48 hrs.No effect of PBS encapsulated liposome against HMG cell and normal fibloblast indicates components of liposome to be harmless for cell growth. The anti-HMG cell effects of Ab-Lip-CDDP significantly increased to 2.1-fold of Lip-CDDP and 20-fold of CDDP in vitro. The Fab'-Lip-CDDP effect was, however, almost similar with Lip-CDDP.The tissue platinum concentration of nude mice was increased to 1.4-fold of Lip-CDDP and 2-fold of CDDP in HMG tumor, and decreased to 0.7-fold of Lip-CDDP and 0.5-fold of CDDP in kidney.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
福森哲也,森厚,幹眞登可,田川俊郎,村田睦男,他.: "Carboplatin封入Liposomeの抗腫瘍効果の検討" 日本口腔科学会雑誌. 42. 934 (1993)
Tetsuya Fukumori、Atsushi Mori、Toki Mikimasa、Toshiro Takawa、Mutsuo Murata 等:“卡铂封装脂质体的抗肿瘤作用的检查”日本口腔医学会杂志 42. 934 (1993)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
福森哲也,乾眞登可,森厚,野村城二,田川俊郎,他.: "シスプラチン封入リポソームを用いた実験的化学療法" 日本口腔外科学会雑誌. (投稿中).
Tetsuya Fukumori、Makoto Inui、Atsushi Mori、Joji Nomura、Toshiro Takawa 等人:“使用顺铂封装脂质体的实验化疗”日本口腔颌面外科学会杂志(正在提交)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
福森哲也,乾眞登可,田川俊郎,村田睦男,他.: "Carboplatin封入Liposomeの口腔悪性腫瘍細胞株に対する効果" 三重医学. 37. 311 (1993)
Tetsuya Fukumori、Makoto Inui、Toshiro Takawa、Mutsuo Murata 等:“卡铂封装的脂质体对口腔恶性肿瘤细胞系的影响” Mie Medical。 37. 311 (1993)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
福森 哲也,紀平 浩之,村田 琢,西井 正高,田中 礼子,松本 淳,大西 誠,後藤 亮,田川 俊郎: "Cisplatin封入LiposomeのHMG細胞に対する効果ーMTT ussayによる検討ー" 日本口腔外科学会雑誌. 38. 1997- (1992)
Tetsuya Fukumori、Hiroyuki Kihira、Taku Murata、Masataka Nishii、Reiko Tanaka、Jun Matsumoto、Makoto Onishi、Ryo Goto、Toshiro Takawa:“顺铂封装脂质体对 HMG 细胞的影响 - MTT ussay 研究” 日本口腔学会杂志和颌面外科。38.1997-(1992)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 15 条
    The study of tumor growth inhibiting activity purified from conditioned medium of human malignant melanoma cells
    • 批准号:
      12470436
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.36万
    • 财政年份:
      2000
    • 负责人:
      INUI Madoka
    • 依托单位:
    国内基金
    海外基金
    Microbubble-ZPDGFRβ/PFD/liposome通过靶向肝星状细胞改善肿瘤微环境抑制肝细胞癌复发转移的作用及机制研究
    • 批准号:
      82272000
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      杨秀华
    • 依托单位:
    基于Gd-HPDO3A@Liposome-Ga-68的PET/MR用于肝肿瘤增强显像及酸碱微环境检测